Bracey Art, Shander Aryeh, Aronson Solomon, Boucher Bradley A, Calcaterra Domenico, Chu Michael W A, Culbertson Richard, Jabr Karim, Kehlet Henrik, Lattouf Omar, Malaisrie S Chris, Mazer C David, Oberhoffer Martin M, Ozawa Sherri, Price Theolyn, Rosengart Todd, Spiess Bruce D, Turchetti Giuseppe
Department of Pathology, Baylor St. Luke's Hospital, Houston, Texas.
Department of Anesthesiology, Critical Care and Hyperbaric Medicine, Englewood Hospital and Medical Center, Englewood, New Jersey.
Ann Thorac Surg. 2017 Jul;104(1):353-360. doi: 10.1016/j.athoracsur.2017.01.096. Epub 2017 Apr 24.
Topical hemostatic agents are used in conjunction with conventional procedures to reduce blood loss. They are often used in cardiothoracic surgery, which is particularly prone to bleeding risks. Variation in their use exists because detailed policy and practice guidelines reflecting the current medical evidence have not been developed to promote best surgical practice in this setting. To address this need, the Society for the Advancement of Blood Management convened an International Hemostatic Expert Panel. This article reviews the available literature and sets out evidence-based recommendations for the use of topical hemostatic agents in cardiothoracic surgery.
局部止血剂与传统手术方法联合使用以减少失血。它们常用于心胸外科手术，而该手术特别容易出现出血风险。由于尚未制定反映当前医学证据的详细政策和实践指南以促进该领域的最佳手术实践，其使用存在差异。为满足这一需求，血液管理促进协会召集了一个国际止血专家小组。本文回顾了现有文献，并提出了心胸外科手术中使用局部止血剂的循证建议。
